About Krueppel-like factor 5
Krueppel-like factor 5 (KLF5) is a protein
from Homo sapiens identified by UniProt accession
Q13887, 457 residues long.
MolForge cross-references it against 0 known binders and
339 disease associations.
Target properties
| Protein name | Krueppel-like factor 5 |
| UniProt accession | Q13887 |
| Gene | KLF5 |
| Organism | Homo sapiens |
| Length | 457 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (339)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.52
- monocyte count · score 0.38
- cervical squamous cell carcinoma · score 0.37
- colorectal cancer · score 0.36
- squamous cell lung carcinoma · score 0.34
- Eczematoid dermatitis · score 0.34
- urinary bladder cancer · score 0.34
- dilated cardiomyopathy 1FF · score 0.33
- neutrophil count · score 0.33
- colorectal adenoma · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13887-F1 | alphafold | PREDICTED | 46.88 | — |
Amino-acid sequence (457 residues)
MATRVLSMSA RLGPVPQPPA PQDEPVFAQL KPVLGAANPA RDAALFPGEE LKHAHHRPQA QPAPAQAPQP AQPPATGPRL PPEDLVQTRC EMEKYLTPQL PPVPIIPEHK KYRRDSASVV DQFFTDTEGL PYSINMNVFL PDITHLRTGL YKSQRPCVTH IKTEPVAIFS HQSETTAPPP APTQALPEFT SIFSSHQTAA PEVNNIFIKQ ELPTPDLHLS VPTQQGHLYQ LLNTPDLDMP SSTNQTAAMD TLNVSMSAAM AGLNTHTSAV PQTAVKQFQG MPPCTYTMPS QFLPQQATYF PPSPPSSEPG SPDRQAEMLQ NLTPPPSYAA TIASKLAIHN PNLPTTLPVN SQNIQPVRYN RRSNPDLEKR RIHYCDYPGC TKVYTKSSHL KAHLRTHTGE KPYKCTWEGC DWRFARSDEL TRHYRKHTGA KPFQCGVCNR SFSRSDHLAL HMKRHQN
Explore Krueppel-like factor 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets